These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27628319)

  • 1. Expression of ADAM10, Fas, FasL and Soluble FasL in Patients with Oral Squamous Cell Carcinoma (OSCC) and their Association with Clinical-Pathological Parameters.
    Zepeda-Nuño JS; Guerrero-Velázquez C; Del Toro-Arreola S; Vega-Magaña N; Ángeles-Sánchez J; Haramati J; Pereira-Suárez AL; Bueno-Topete MR
    Pathol Oncol Res; 2017 Apr; 23(2):345-353. PubMed ID: 27628319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.
    Ko SY; Lin SC; Wong YK; Liu CJ; Chang KW; Liu TY
    Cancer Lett; 2007 Jan; 245(1-2):33-43. PubMed ID: 16309826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of FasL expression in oral squamous cell cancer.
    Fang L; Sun L; Hu FF; Chen QE
    Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin.
    Jones AV; Lambert DW; Speight PM; Whawell SA
    FEBS Lett; 2013 Nov; 587(21):3529-34. PubMed ID: 24055471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway.
    Liu WH; Chang LS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1708-19. PubMed ID: 21854868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death.
    Schulte M; Reiss K; Lettau M; Maretzky T; Ludwig A; Hartmann D; de Strooper B; Janssen O; Saftig P
    Cell Death Differ; 2007 May; 14(5):1040-9. PubMed ID: 17290285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.
    Chien MH; Chang WM; Lee WJ; Chang YC; Lai TC; Chan DV; Sharma R; Lin YF; Hsiao M
    Mol Cancer Ther; 2017 Jun; 16(6):1102-1113. PubMed ID: 28292939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ADAM10 in oral squamous cell carcinoma with metastases.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Kulicka P; Danilewicz M
    Pol J Pathol; 2018; 69(1):67-72. PubMed ID: 29895129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAS ligand expression in inflammatory infiltrate lymphoid cells as a prognostic marker in oral squamous cell carcinoma.
    Peterle GT; Santos M; Mendes SO; Carvalho-Neto PB; Maia LL; Stur E; Agostini LP; Silva CV; Trivilin LO; Nunes FD; Carvalho MB; Tajara EH; Louro ID; Silva-Conforti AM
    Genet Mol Res; 2015 Sep; 14(3):11145-53. PubMed ID: 26400345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Fas/FasL in patients with oral lichen planus.
    Hadzi-Mihailovic M; Raybaud H; Monteil R; Jankovic L
    J BUON; 2009; 14(3):487-93. PubMed ID: 19810143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma.
    Loro LL; Vintermyr OK; Johannessen AC; Liavaag PG; Jonsson R
    J Oral Pathol Med; 1999 Feb; 28(2):82-7. PubMed ID: 9950255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
    Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.
    Das SN; Khare P; Singh MK; Sharma SC
    Indian J Med Res; 2011 Jul; 134(1):54-60. PubMed ID: 21808135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitoylation of human FasL modulates its cell death-inducing function.
    Guardiola-Serrano F; Rossin A; Cahuzac N; Lückerath K; Melzer I; Mailfert S; Marguet D; Zörnig M; Hueber AO
    Cell Death Dis; 2010 Oct; 1(10):e88. PubMed ID: 21368861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
    Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
    J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus.
    Kozlowski M; Kowalczuk O; Sulewska A; Dziegielewski P; Lapuc G; Laudanski W; Niklinska W; Chyczewski L; Niklinski J; Laudanski J
    Folia Histochem Cytobiol; 2007; 45(3):199-204. PubMed ID: 17951168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
    Daripally S; Nallapalle SR; Katta S; Prasad VV
    Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the relationship between Fas expression and apoptosis in oral squamous cell carcinoma].
    Wang JG; Huang HZ; Pan CB; Hou JS; Li JS; Cheng B
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Aug; 22(4):334-6. PubMed ID: 15379323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased ADAM10 expression in patients with immune thrombocytopenia.
    Qiao J; Luo Q; Liu N; Wei G; Wu X; Lu J; Tang K; Wu Y; Zi J; Li X; Liu Y; Ju W; Qi K; Yan Z; Li Z; Zeng L; Xu K
    Int Immunopharmacol; 2018 Feb; 55():63-68. PubMed ID: 29223855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Slit-Robo signal on apoptosis of oral cancer cell line Tb].
    Ma YG; Wang LJ; Han B; Zhang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Apr; 41(4):232-5. PubMed ID: 16784591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.